TOKYO -- Takeda Pharmaceutical plans to sell its over-the-counter medicine business, looking to reduce a massive debt load after last year's purchase of Irish drugmaker Shire and tighten its focus on advanced treatments, Nikkei learned Friday.
Japan's biggest drug company is talking with financial institutions to choose a potential buyer for wholly owned subsidiary Takeda Consumer Healthcare, aiming to sell for around 400 billion yen ($3.71 billion).
